INDIANA – Today, the FDA and CTTI announced the call for applications for new Patient Engagement Collaborative (PEC) members. The PEC is an ongoing, shared forum in which the patient community (PEC members), FDA, and CTTI discuss a variety of topics such as improving communication, education, and patient engagement related to medical product regulation.
PEC members participate in two to four virtual meetings per year. Other meetings may be organized, as needed. PEC members are expected to serve for two years. Up to 8 new members will be selected.
The following individuals are encouraged to apply:
• Patients who have personal disease experience
• Caregivers who directly support patients (e.g., a family member or friend) and have personal disease experience through this caregiver role
• Representatives from patient groups who, through their role in the patient group, have direct or indirect disease experience
The following PDF format documents are required to apply and must be submitted at the same time:
• A current and complete one- to two-page resume or bio that summarizes your patient advocacy experience and related activities; and
• A one-page professional letter of endorsement from a patient group with which you have worked closely on activities that are relevant to the PEC
This announcement is open to receive a maximum of 75 applications. Applications will be accepted until 11:59 p.m. Eastern Time on August 14, 2023 or until 75 complete applications are received, whichever happens first.
Interested candidates are encouraged to apply early. Please review the related Federal Register Notice for important information about the application process.
Applicants will be selected based on their ability to meaningfully contribute to the PEC, represent and express the patient voice for their constituency, work in a constructive manner with involved stakeholders, and understand and navigate the clinical research system.
Understanding patients’ experiences is critical to support medical product regulation and help ensure safe, effective and innovative medical products are available. We encourage interested individuals to apply for this unique opportunity to help advance public health.
Contact PatientEngagementCollaborative@fda.hhs.gov with questions.
For more information:
• Federal Register Notice
• PEC Application
• Learn about PEC and How to Apply
• Patient Engagement Collaborative
• 2023 PEC Framework
